{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-26-000133","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2026-06-18T20:19:08+00:00","discovered_at":"2026-06-18T20:20:00.254244+00:00","generated_at":"2026-06-18T20:29:20.095081+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"GoodRx stockholders elect three Class III directors and ratify KPMG as auditor at 2026 annual meeting","bullets":["Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre elected as Class III directors with >99% of votes cast FOR.","Ratification of KPMG LLP as independent auditor for FY 2026 received 2,429,055,999 votes FOR (99.98% of votes cast).","Advisory (non-binding) approval of named executive officer compensation passed with 2,363,913,370 votes FOR (~98.9% of votes cast).","Approximately 99.4% of combined voting power represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-26-000133","json":"https://secwatch.observer/filing/0001809519-26-000133.json","markdown":"https://secwatch.observer/filing/0001809519-26-000133.md","text":"https://secwatch.observer/filing/0001809519-26-000133.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000133/0001809519-26-000133-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000133/gdrx-20260616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T20:29:20.095081+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5d3dca02a8ac77d22f7f70ec015bf918d7c75d29","claim":"GoodRx Holdings, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-16 meeting.","evidence_excerpt":"Item 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 2,429,055,999 335,716 183,106 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000133/0001809519-26-000133-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"},{"claim_id":"8ea8abe5301118becf99dab29d0f8aee3235948f","claim":"GoodRx Holdings, Inc. shareholders approved Election of three Class III directors at the 2026-06-16 meeting.","evidence_excerpt":"Item 1 — Election of three Class III directors for a term of office expiring on the date of the Annual Meeting of Stockholders to be held in 2029 and until their respective successors have been duly elected and qualified or until their respective earlier death, resignation or removal. Votes FOR Votes WITHHELD Broker Non-Votes Wendy Barnes 2,379,952,868 10,078,860 39,543,093 Ronald E. Bruehlman 2,380,863,641 9,168,087 39,543,093 Gregory Mondre 2,382,474,121 7,557,607 39,543,093","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000133/0001809519-26-000133-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"},{"claim_id":"bfed4e64fe185dc8ece73669b6dc55cc2dfe406b","claim":"GoodRx Holdings, Inc. shareholders approved Advisory (non-binding) vote on the compensation of the named executive officers. at the 2026-06-16 meeting.","evidence_excerpt":"Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 2,363,913,370 23,702,520 2,415,838 39,543,093","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000133/0001809519-26-000133-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}